Corcept Therapeutics Inc. buy Truist Financial Co.
Start price
31.03.25
/
50%
€93.70
Target price
31.03.26
€138.36
Performance (%)
-35.05%
Price
05.08.25
€60.86
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc. is performing very badly with a performance of -35.05%. This prediction currently runs until 31.03.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corcept Therapeutics Inc. | 3.921% | 3.921% |
| iShares Core DAX® | -0.695% | 0.275% |
| iShares Nasdaq 100 | -0.520% | 3.779% |
| iShares Nikkei 225® | 0.870% | 1.365% |
| iShares S&P 500 | -0.737% | 3.346% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $76.00 to $150.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.88
30.09.24
30.09.24
€68.09
30.09.25
30.09.25
45.32%
05.08.25
05.08.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.62
17.06.24
17.06.24
€60.58
17.06.25
17.06.25
137.04%
18.06.25
18.06.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.31
04.06.24
04.06.24
€59.79
04.06.25
04.06.25
104.22%
05.06.25
05.06.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.88
02.05.24
02.05.24
€41.15
02.05.25
02.05.25
181.82%
03.05.25
03.05.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.60
16.02.24
16.02.24
€39.06
16.02.25
16.02.25
204.07%
17.02.25
17.02.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
06.11.23
06.11.23
€35.38
06.11.24
06.11.24
112.42%
07.11.24
07.11.24